Apollo Medical Holdings, Inc. Stock: price and insider trades · United States · SEC (Form 4)

About Apollo Medical Holdings, Inc.

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) is a U.S.-listed healthcare company traded on the NASDAQ market in the United States. The company has built its franchise around integrated medical management and value-based care, with roots tracing back to 1994 through Network Medical Management, a physician-led organization headquartered in Alhambra, California. Over time, Apollo Medical Holdings expanded through mergers, acquisitions, and strategic combinations, creating a broader platform for care coordination, provider enablement, and risk-bearing healthcare management. Its corporate headquarters is in Alhambra, California, United States. The company’s business model centers on management services organizations (MSOs), affiliated independent practice associations (IPAs), and participation in CMS innovation models. In practical terms, ApolloMed sits between patients, physicians, hospitals, health plans, and other care providers, helping coordinate care delivery, manage utilization, improve clinical outcomes, and support lower-cost care pathways. Its service set includes hospitalist services, care management, population health management, analytics, and technology-enabled workflows designed to support value-based reimbursement arrangements. From a competitive standpoint, ApolloMed is positioned as a physician-centric, technology-powered healthcare operator in the fragmented but highly regulated U.S. managed care ecosystem. Its differentiation comes from combining clinical integration with administrative and analytical capabilities, while building networks that serve insured populations, including Medicare and Medicaid members as well as commercial patients. The company has historically concentrated on California, with a meaningful footprint across Southern, Central, and Northern California, and it has worked to deepen relationships across medical groups, IPAs, hospitals, and payers. Recent strategic developments underscore ApolloMed’s emphasis on platform expansion and care delivery partnerships. In 2022, the company acquired Orma Health to strengthen its technology and analytics stack for provider solutions. In 2023, ApolloMed announced a strategic partnership with Wider Circle to support Enhanced Care Management for high-need Medicaid members across California. In 2024, it also announced a long-term partnership with BASS Medical Group in the greater San Francisco Bay Area. Collectively, these moves point to a growth strategy focused on geographic expansion, tighter provider alignment, and further integration of technology into care management. For investors tracking SEC Form 4 insider transactions, this operating backdrop is relevant because the company’s insider activity occurs within a business still evolving through partnerships, platform investments, and network consolidation on the NASDAQ in the United States.